Foresight Regulatory Strategies, Inc. (FRS) is a team of professionals who provide support to medical device, pharmaceutical and biologic companies for a variety of clinical, quality and regulatory activities during all phases of the product life cycle. Founded in January 1997 by William Gleason, O.D., Ellen Beucler, Beverley Venuti, Ph.D. and Ann Kurowski, and later joined in 1999 by Roger Albright, FRS is a team of scientific professionals with a clear understanding of the global standards and requirements necessary during product development.Members of this team have worked together for over twenty years and have a proven track record of faster and more cost-effective product approvals.
Our team understands the importance of interfacing with scientific and marketing professionals in a cross-functional environment at all stages of product evolution and have a proven track record of faster and more cost-effective product approvals. Our scientific expertise enhances our understanding of research and development processes, resulting in the development of clinical investigational plans, product marketing submissions and quality systems that best meet the needs of worldwide regulatory agencies.
Our specialty is ophthalmic devices; however, we have provided our clients with assistance in various aspects of clinical, regulatory and quality system services for ophthalmic drugs and a variety of non-ophthalmic devices, drugs and biologics.Our clients have included companies who develop and manufacture contact lenses and lens care products, ophthalmic pharmaceuticals, cancer therapies, vaccines, surgical accessories, wound healing products and veterinary products.
187 Ballardvale Street, Suite 180 Wilmington, MA01887-4461 TEL (978).658-6888, FAX (978) 658-6803